T-MAXIMUM PHARMACEUTICAL

T-maximum pharmaceutical email format

Verified email-pattern data for T-Maximum Pharmaceutical is currently limited. You can still use the company insights and contact sections below.
T-MAXIMUM Pharmaceutical (T-MAXIMUM) is a clinical-stage biotech company based in Suzhou, China focusing on the development of allogeneic universal CAR-T cell therapies for solid tumors. It’s core technology platform utilizes a fully proprietary gene-edited immuno-cellular therapy approach. This approach limits the risks of graft-versus-host disease and rejection, allowing allogeneic CAR-T cells persist within the patient's body for an extended period, thereby achieving optimal therapeutic effects with Best-in-Class potential. T-MAXIMUM is currently focusing on advanced-stage malignancies, with its lead pipeline product for recurrent high-grade glioma (rHGG) demonstrating breakthrough efficacy and manageable safety in initial clinical studies and obtained Orphan Drug Designation (ODD) from the US FDA.
Looking for a particular T-MAXIMUM PHARMACEUTICAL employee's phone or email?

T-Maximum Pharmaceutical Questions

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant